Abstract
The stem cells isolated from amniotic fluid present an exciting possible contribution to the field of regenerative medicine and amniotic fluid-derived stem (AFS) cells have significant potential for research and therapeutic applications. AFS cells are multipotent, showing the ability to differentiate into cell types from all three embryonic germ layers. They express both embryonic and adult stem cell markers, expand extensively without feeder cells, double in 36 h, and are not tumorigenic. The AFS cells can be maintained for over 250 population doublings and preserve their telomere length and a normal karyotype. They differentiate easily into specific cell lineages and do not require human embryo tissue for their isolation, thus avoiding the current controversies associated with the use of human embryonic stem (ES) cells. The discovery of the AFS cells has been recent, and a great deal of work remains to be performed on the characterization and use of these cells. This review describes the various differentiated lineages that AFS cells can form and the future of these promising new stem cells in regenerative medicine research.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Atala, A., Bauer, S. B., Soker, S., Yoo, J. J., and Retik, A. B., Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet, 367, 1241–1246 (2006).
Atala, A., Engineering tissues, organs and cells. J. Tissue Eng. Regen. Med., 1, 83–96 (2007).
Atala, A., Amniotic Fluid-Derived Pluripotential Cells. Chapter 16 in Essentials of Stem Cell Biology. Elsevier Inc., 145–150 (2009).
Bollini, S., Pozzobon, M., Nobles, M., Riegler, J., Dong, X., Piccoli, M., Chiavegato, A., Price, A. N., Ghionzoli, M., Cheung, K. K., Cabrelle, A., O’mahoney, P. R., Cozzi, E., Sartore, S., Tinker, A., Lythgoe, M. F., and De Coppi, P., In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells. Stem Cell Rev., 7, 364–380 (2011).
Brace, R. A., Ross, M. G., and Robillard, J. E., Fetal and neonatal body fluids: The scientific basis for clinical practice. Perinatology Press, New York, (1989).
Bryan, T. M., Englezou, A., Dunham, M. A., and Reddel, R. R., Telomere length dynamics in telomerase-positive immortal human cell populations. Exp. Cell Res., 239, 370–378 (1998).
Caplan, A. I. and Dennis, J. E., Mesenchymal stem cells as trophic mediators. J. Cell. Biochem., 98, 1076–1084 (2006).
Carraro, G., Perin, L., Sedrakyan, S., Giuliani, S., Tiozzo, C., Lee, J., Turcatel, G., De Langhe, S. P., Driscoll, B., Bellusci, S., Minoo, P., Atala, A., De Filippo, R. E., and Warburton, D., Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells, 26, 2902–2911 (2008).
Chazan, J. A., Libbey, N. P., London, M. R., Pono, L., and Abuelo, J. G., The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings. Clin. Nephrol., 35, 78–85 (1991).
Cremer, M., Schachner, M., Cremer, T., Schmidt, W., and Voigtlander, T., Demonstration of astrocytes in cultured amniotic fluid cells of three cases with neural-tube defect. Hum. Genet., 56, 365–370 (1981).
De Coppi, P., Bartsch, G., Jr., Siddiqui, M. M., Xu, T., Santos, C. C., Perin, L., Mostoslavsky, G., Serre, A. C., Snyder, E. Y., Yoo, J. J., Furth, M. E., Soker, S., and Atala, A., Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol., 25, 100–106 (2007a).
De Coppi, P., Callegari, A., Chiavegato, A., Gasparotto, L., Piccoli, M., Taiani, J., Pozzobon, M., Boldrin, L., Okabe, M., Cozzi, E., Atala, A., Gamba, P., and Sartore, S., Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J. Urol., 177, 369–376 (2007b).
Fauza, D. O., Marler, J. J., Koka, R., Forse, R. A., Mayer, J. E., and Vacanti, J. P., Fetal tissue engineering: diaphragmatic replacement. J. Pediatr. Surg., 36, 146–151 (2001).
Fuchs, J. R., Kaviani, A., Oh, J. T., Lavan, D., Udagawa, T., Jennings, R. W., Wilson, J. M., and Fauza, D. O., Diaphragmatic reconstruction with autologous tendon engineered from mesenchymal amniocytes. J. Pediatr. Surg., 39, 834–838; discussion 834–838 (2004).
Kolambkar, Y. M., Peister, A., Soker, S., Atala, A., and Guldberg, R. E., Chondrogenic differentiation of amniotic fluid-derived stem cells. J. Mol. Histol., 38, 405–413 (2007).
Kunisaki, S. M., Fuchs, J. R., Steigman, S. A., and Fauza, D. O., A comparative analysis of cartilage engineered from different perinatal mesenchymal progenitor cells. Tissue Eng., 13, 2633–2644 (2007).
Langer, R. and Vacanti, J. P., Tissue engineering. Science, 260, 920–926 (1993).
Lee, W. Y., Wei, H. J., Lin, W. W., Yeh, Y. C., Hwang, S. M., Wang, J. J., Tsai, M. S., Chang, Y., and Sung, H. W., Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stemcell bodies enriched with endogenous ECM. Biomaterials, 32, 5558–5567 (2011).
Medina-Gomez, P. and Johnston, T. H., Cell morphology in long-term cultures of normal and abnormal amniotic fluids. Hum. Genet., 60, 310–313 (1982).
Menasche, P., Cell-based therapy for heart disease: a clinically oriented perspective. Mol. Ther., 17, 758–766 (2009).
Ojo, A. O., Hanson, J. A., Wolfe, R. A., Leichtman, A. B., Agodoa, L. Y., and Port, F. K., Long-term survival in renal transplant recipients with graft function. Kidney Int., 57, 307–313 (2000).
Ojo, A. O., Hanson, J. A., Meier-Kriesche, H., Okechukwu, C. N., Wolfe, R. A., Leichtman, A. B., Agodoa, L. Y., Kaplan, B., and Port, F. K., Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J. Am. Soc. Nephrol., 12, 589–597 (2001).
Pan, G. J., Chang, Z. Y., Scholer, H. R., and Pei, D., Stem cell pluripotency and transcription factor Oct4. Cell Res., 12, 321–329 (2002).
Peister, A., Deutsch, E. R., Kolambkar, Y., Hutmacher, D. W., and Guldberg, R. E. Amniotic fluid stem cells produce robust mineral deposits on biodegradable scaffolds. Tissue Eng. Part A, 15, 3129–3138 (2009).
Perin, L., Giuliani, S., Jin, D., Sedrakyan, S., Carraro, G., Habibian, R., Warburton, D., Atala, A., and De Filippo, R. E., Renal differentiation of amniotic fluid stem cells. Cell Prolif., 40, 936–948 (2007).
Perin, L., Sedrakyan, S., Giuliani, S., Da Sacco, S., Carraro, G., Shiri, L., Lemley, K. V., Rosol, M., Wu, S., Atala, A., Warburton, D., and De Filippo, R. E., Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS ONE, 5, e9357 (2010).
Polgar, K., Adany, R., Abel, G., Kappelmayer, J., Muszbek, L., and Papp, Z., Characterization of rapidly adhering amniotic fluid cells by combined immunofluorescence and phagocytosis assays. Am. J. Hum. Genet., 45, 786–792 (1989).
Pozzobon, M., Ghionzoli, M., and De Coppi, P., ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective. Pediatr. Surg. Int., 26, 3–10 (2010).
Prasongchean, W., Bagni, M., Calzarossa, C., De Coppi, P., and Ferretti, P., Amniotic fluid stem cells increase embryo survival following injury. Stem Cells Dev., DOI 10.1089/scd.2011.0281 (2011).
Priest, R. E., Marimuthu, K. M., and Priest, J. H., Origin of cells in human amniotic fluid cultures: ultrastructural features. Lab. Invest., 39, 106–109 (1978).
Raya-Rivera, A., Esquiliano, D. R., Yoo, J. J., Lopez-Bayghen, E., Soker, S., and Atala, A., Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet, 377, 1175–1182 (2011).
Steigman, S. A., Ahmed, A., Shanti, R. M., Tuan, R. S., Valim, C., and Fauza, D. O., Sternal repair with bone grafts engineered from amniotic mesenchymal stem cells. J. Pediatr. Surg., 44, 1120–1126; discussion 1126 (2009).
Sun, H., Feng, K., Hu, J., Soker, S., Atala, A., and Ma, P. X., Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials, 31, 1133–1139 (2010).
Teodelinda, M., Michele, C., Sebastiano, C., Ranieri, C., and Chiara, G., Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neoarteriogenesis in an ischemic model. Biomaterials, 32, 3689–3699 (2011).
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., and Jones, J. M., Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145–1147 (1998).
Trounson, A., A fluid means of stem cell generation. Nat. Biotechnol., 25, 62–63 (2007).
Von Koskull, H., Virtanen, I., Lehto, V. P., Vartio, T., Dahl, D., and Aula, P., Glial and neuronal cells in amniotic fluid of anencephalic pregnancies. Prenat. Diagn., 1, 259–267 (1981).
Weber, B., Zeisberger, S. M., and Hoerstrup, S. P. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth. Placenta, 32Suppl 4, S316–S319 (2011).
Yeh, Y. C., Lee, W. Y., Yu, C. L., Hwang, S. M., Chung, M. F., Hsu, L. W., Chang, Y., Lin, W. W., Tsai, M. S., Wei, H. J., and Sung, H. W., Cardiac repair with injectable cell sheet fragments of human amniotic fluid stem cells in an immune-suppressed rat model. Biomaterials, 31, 6444–6453 (2010a).
Yeh, Y. C., Wei, H. J., Lee, W. Y., Yu, C. L., Chang, Y., Hsu, L. W., Chung, M. F., Tsai, M. S., Hwang, S. M., and Sung, H. W., Cellular cardiomyoplasty with human amniotic fluid stem cells: in vitro and in vivo studies. Tissue Eng. Part A, 16, 1925–1936 (2010b).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Joo, S., Ko, I.K., Atala, A. et al. Amniotic fluid-derived stem cells in regenerative medicine research. Arch. Pharm. Res. 35, 271–280 (2012). https://doi.org/10.1007/s12272-012-0207-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-012-0207-7